Pre-order Enquiry
Request Free Sample
Global Coronary Atherectomy Devices Market Research Report 2021
SKU ID : QYR-17140902 | Publishing Date : 09-Jan-2021 | No. of pages : 92
Request Sample
Request Customization
Check Discounts
Atherectomy is defined as minimally invasive surgery for removal of plaque blockages from coronary.
Atherectomy is a minimally invasive endovascular surgery technique for removing atherosclerosis from blood vessels within the body. It is an alternative to angioplasty for the treatment of peripheral artery disease, but the studies that exist are not adequate to determine if it is superior to angioplasty.
The classification of Coronary Atherectomy Devices includes Laser Atherectomy, Orbital Atherectomy, Rotational Atherectomy and Others and the proportion of Laser Atherectomy in 2017 is about 38.3%.
Coronary Atherectomy Devices is widely used in Hospitals, Clinics and Ambulatory Surgery Centers. The most proportion of Coronary Atherectomy Devices is used in hospital, and the proportion in 2017 is 63.8%.
North America is the largest consumption place, with a consumption market share nearly 86.7% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 10%.
Market competition is not intense. Boston Scientific, Philips, Cardiovascular Systems, etc. are the leaders of the industry, with high-end customers.
The global Coronary Atherectomy Devices market was valued at US$ 224 million in 2019 and is expected to reach US$ 352.8 million by the end of 2026, growing at a CAGR of 6.6% during 2021-2026.
This report focuses on Coronary Atherectomy Devices volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Coronary Atherectomy Devices market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Coronary Atherectomy Devices Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Laser Atherectomy
Orbital Atherectomy
Rotational Atherectomy
Others
Segment by Application
Hospitals
Clinics
Ambulatory Surgery Centers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Boston Scientific
Philips
Cardiovascular Systems
Atherectomy is a minimally invasive endovascular surgery technique for removing atherosclerosis from blood vessels within the body. It is an alternative to angioplasty for the treatment of peripheral artery disease, but the studies that exist are not adequate to determine if it is superior to angioplasty.
The classification of Coronary Atherectomy Devices includes Laser Atherectomy, Orbital Atherectomy, Rotational Atherectomy and Others and the proportion of Laser Atherectomy in 2017 is about 38.3%.
Coronary Atherectomy Devices is widely used in Hospitals, Clinics and Ambulatory Surgery Centers. The most proportion of Coronary Atherectomy Devices is used in hospital, and the proportion in 2017 is 63.8%.
North America is the largest consumption place, with a consumption market share nearly 86.7% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 10%.
Market competition is not intense. Boston Scientific, Philips, Cardiovascular Systems, etc. are the leaders of the industry, with high-end customers.
The global Coronary Atherectomy Devices market was valued at US$ 224 million in 2019 and is expected to reach US$ 352.8 million by the end of 2026, growing at a CAGR of 6.6% during 2021-2026.
This report focuses on Coronary Atherectomy Devices volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Coronary Atherectomy Devices market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Coronary Atherectomy Devices Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Laser Atherectomy
Orbital Atherectomy
Rotational Atherectomy
Others
Segment by Application
Hospitals
Clinics
Ambulatory Surgery Centers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Boston Scientific
Philips
Cardiovascular Systems
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
